These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23594698)

  • 1. Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.
    Basaras M; Arrese E; Blanco S; Arroyo LS; Ruiz P; Cisterna R
    Intervirology; 2013; 56(3):190-4. PubMed ID: 23594698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
    Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
    J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
    Mese S; Arikan M; Cakiris A; Abaci N; Gumus E; Kursun O; Onel D; Ustek D; Kaymakoglu S; Badur S; Yenen OS; Bozkaya E
    J Gen Virol; 2013 Dec; 94(Pt 12):2729-2738. PubMed ID: 24045109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant Hepatitis B virus.
    Chantratita W; Song KS; Pongthanapisith V; Thongbaiphet N; Angkanavin K; Nimse SB; Sonawane MD; Kim T
    J Virol Methods; 2016 Nov; 237():58-63. PubMed ID: 27581951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
    Aydoğan S; Ergünay K; Balaban Y; Alp A; Simşek H; Tatar G; Hasçelik G; Us D
    Mikrobiyol Bul; 2013 Jul; 47(3):472-81. PubMed ID: 23971924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of therapy in patients with chronic hepatitis B virus.
    Arrese E; Basaras M; Blanco S; Ruiz P; Cisterna R
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance.
    Choi YJ; Kim HS; Lee SH; Park JS; Nam HS; Kim HJ; Kim CJ; Jeong DJ; Park KS; Baek KA
    Arch Virol; 2011 Sep; 156(9):1517-24. PubMed ID: 21594598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy.
    Jardi R; Rodriguez-Frias F; Schaper M; Giggi E; Tabernero D; Homs M; Esteban R; Buti M
    J Hepatol; 2008 Nov; 49(5):695-701. PubMed ID: 18490074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    Selabe SG; Song E; Burnett RJ; Mphahlele MJ
    J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.
    Aberle SW; Kletzmayr J; Watschinger B; Schmied B; Vetter N; Puchhammer-Stöckl E
    J Clin Microbiol; 2001 May; 39(5):1972-4. PubMed ID: 11326026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
    Ağca H; Sayıner AA; Sengönül A; Simşek I; Akarsu M
    Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
    Woo HY; Park H; Kim BI; Jeon WK; Cho YK; Kim YJ
    Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
    Akarsu M; Sengonul A; Tankurt E; Sayiner AA; Topalak O; Akpinar H; Abacioglu YH
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
    Salpini R; Svicher V; Cento V; Gori C; Bertoli A; Scopelliti F; Micheli V; Cappiello T; Spanò A; Rizzardini G; De Sanctis GM; Sarrecchia C; Angelico M; Perno CF
    Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
    Lok AS; Zoulim F; Locarnini S; Mangia A; Niro G; Decraemer H; Maertens G; Hulstaert F; De Vreese K; Sablon E
    J Clin Microbiol; 2002 Oct; 40(10):3729-34. PubMed ID: 12354872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay.
    Roque-Afonso AM; Férey MP; Mackiewicz V; Fki L; Dussaix E
    Antivir Ther; 2003 Dec; 8(6):627-34. PubMed ID: 14760897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of hepatitis B virus mutations related to adefovir dipivoxil among patients with chronic hepatitis B virus infection in eastern Zhejiang province].
    Hu AR; Jiang SW; Li L; Ding SX; Hu YR; Liang XY
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1878-81. PubMed ID: 23134956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.
    Kim HS; Han KH; Ahn SH; Kim EO; Chang HY; Moon MS; Chung HJ; Yoo W; Kim SO; Hong SP
    Antivir Ther; 2005; 10(3):441-9. PubMed ID: 15918335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4.
    Zekri AR; El-Din HM; Bahnassy AA; El-Shehabi AM; El-Leethy H; Omar A; Khaled HM
    J Med Virol; 2005 Mar; 75(3):412-20. PubMed ID: 15648068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.
    Olivero A; Ciancio A; Abate ML; Gaia S; Smedile A; Rizzetto M
    J Viral Hepat; 2006 Jun; 13(6):355-62. PubMed ID: 16842437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.